VJHemOnc is committed to improving our service to you

MPN Advances Day 2019 | The role of interferon in PV

VJHemOnc is committed to improving our service to you

Jean-Jacques Kiladjian

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital, University of Paris, Paris, France, explains our current understanding of the role of interferon in polycythemia vera (PV) management. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter